HIV cure research – free webinar

Gus Cairns
Published: 28 May 2013

As part of its European HIV prevention work, NAM is collaborating with AVAC to provide a series of webinars (conference calls with accompanying slides) to train and inform prevention advocates and anyone interested in the newest developments in HIV prevention technology.

The fifth webinar is entitled:

European research towards a cure for HIV

Recently several stories have appeared in national newspapers and magazines over-optimistically predicting that HIV may be curable soon. It is timely therefore that the fifth webinar in our series will look at recent developments in the area of cure research.

Speakers include Dr Rowena Johnston of the Foundation for AIDS Research (AmfAR) and Dr Sarah Fidler of Imperial College.

Time and date: 2pm UK time (BST), Tuesday 11 June (3pm CEST)

To register for the webinar and get phone numbers and joining instructions click this link:

European advocates interested in learning more about HIV treatment as prevention are encouraged to join this webinar and to email questions in advance to The webinar will be 90 minutes long and chaired by Rebekah Webb of AVAC. During the event, participants will be encouraged to ask questions via telephone.

This project has been supported via grants from Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare.

Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare have provided funding for this project and have had no editorial control over the content of the materials.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.